ELEV
Elevation Oncology
ELEV
ELEV
Delisted
ELEV was delisted on the 22nd of July, 2025.
72 hedge funds and large institutions have $8.76M invested in Elevation Oncology in 2025 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 18 increasing their positions, 22 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
18% less repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 22
61% less capital invested
Capital invested by funds: $22.5M → $8.76M (-$13.7M)
Holders
72
Holding in Top 10
1
Calls
$17K
Puts
$1K
Top Buyers
| 1 | +$1.53M | |
| 2 | +$114K | |
| 3 | +$54.1K | |
| 4 |
CIBC Private Wealth Group
Atlanta,
Georgia
|
+$37.4K |
| 5 |
Two Sigma Advisers
New York
|
+$28.2K |
Top Sellers
| 1 | -$1.98M | |
| 2 | -$1.67M | |
| 3 | -$530K | |
| 4 |
Millennium Management
New York
|
-$459K |
| 5 |
Goldman Sachs
New York
|
-$408K |
